A Phase I/II Study of Trimetrexate and Capecitabine in Patients With Advanced Refractory Colorectal Cancer-Reference-Cited by-同舟云学术

A Phase I/II Study of Trimetrexate and Capecitabine in Patients With Advanced Refractory Colorectal Cancer

Published:2005-10 Issue:5 Volume:28 Page:439-444
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:American Journal of Clinical Oncology

Author:

Matin Khalid,Jacobs Samuel A.,Richards Thomas,Wong Michael K.,Earle Martin,Evans Terry,Troetschel Monica,Ferri William,Friedland David,Pinkerton Richard,Volkin Robert,Wieand Samuel,Ramanathan Ramesh K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference26 articles.

1. Cancer Statistics, 2004

2. Colorectal cancer—Is there an alternative to 5-FU?

3. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.

4. Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer.

5. Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. Meta-Analysis Group In Cancer.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective Analysis of S-1 Monotherapy in Patients with Metastatic Colorectal Cancer After Failure to Fluoropyrimidine and Irinotecan or to Fluoropyrimidine, Irinotecan and Oxaliplatin;Japanese Journal of Clinical Oncology;2009-04-29

2. Quelles nouvelles à propos des antimétabolites en oncologie?;Oncologie;2007-11

3. Molecular basis of antifolate resistance;Cancer and Metastasis Reviews;2007-02-27

4. A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens;British Journal of Cancer;2006-11-14

5. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis;Drug Resistance Updates;2006-08